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Atopy and allergic disease form part of an expanding 
field of medicine and include conditions such as 
asthma, allergic rhinitis, allergic conjunctivitis, 
atopic eczema and food and drug allergies, to name 
just a few.
The prevalences of allergic rhinitis and asthma among South 
African (SA) children are as high as 38.5% and 15%, respectively.[1,2] 
Asthma and allergic rhinitis are closely linked, and physicians are well 
aware of this link in the form of the ‘united airway’ theory.[3] It has 
been well described that co-management of these two conditions will 
reduce disease severity and improve quality of life.[3] Aeroallergens 
have been implicated in the pathophysiology of both these disease 
processes.[4] Those implicated include housedust mite (HDM), grass, 
mould and cockroach, among others. However, HDM allergy is the 
most important indoor aeroallergen in SA, affecting allergic patients 
with asthma and allergic rhinitis.[4-6] One study in the Durban region 
found the incidence of HDM allergy among asthmatics to be as high 
as 95%.[7]
Worldwide, there are a number of HDM species involved in 
these atopic disease processes. These include Dermatophagoides 
pteronyssinus, D. farinae, Euroglyphus maynei and Blomia tropicalis. 
The prevalence of these mite species differs geographically.[8] 
Dermatophagoides spp. occur worldwide, and prefer a warm 
and temperate climate with humidity of >55%.[8] Generally the 
prevalence of D. pteronyssinus is higher in areas with higher 
humidity than that required by D. farinae. Australia, New Zealand, 
the UK and Mauritius have a predominance of D. pteronyssinus,[9] 
while D. farinae predominates in South Korea, Jakarta, Indonesia 
and Italy.[9] E. maynei is thought to occur worldwide, but it has 
been poorly studied and the exact incidence and predominance are 
unknown.[8] B. tropicalis is thought to occur most commonly in the 
tropical and subtropical regions of the world, such as Singapore, 
Malaysia, the Philippines and Hong Kong.[9]
B. tropicalis allergy can be proven via in vivo or in vitro methods. 
In vivo methods involve use of skinprick testing (SPT) and in vitro 
methods use of ImmunoCAP (ThermoFisher) assays. The SPT 
and ImmunoCAP test panels currently in use for the identification 
of HDM allergy in SA test only for Dermatophagoides spp. unless 
specifically requested. Dermatophagoides is therefore the most studied 
HDM species in SA, and data relating to the other species are poorly 
defined. There is limited cross-reactivity between Dermatophagoides 
spp. and B. tropicalis, both on SPTs in vivo and IgE binding on 
ImmunoCAP studies in vitro.[10-12] However, there is marked cross-
reactivity between D. pteronyssinus and D. farinae on both tests.[11,12] 
It therefore stands to reason that a positive SPT for D. pteronyssinus 
or D. farinae does not indicate a positive result for B. tropicalis, and 
individual testing for B. tropicalis is necessary to prove B. tropicalis 
allergy. Current testing practices in SA do not include B. tropicalis 
testing other than in the Western Cape region.[2]
Specific immunotherapy offers the only potential cure for 
HDM allergy. Immunotherapy can comprise either sublingual or 
subcutaneous therapy, both of which have been found to be effective 
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Background. Asthma and allergic rhinitis affect 15% and 38% of South African (SA) children, respectively. The housedust mite (HDM) is 
the most significant indoor aeroallergen. Typical HDM species include Dermatophagoides pteronyssinus, D. farinae and Blomia tropicalis. 
Conventional skin-prick testing (SPT) panels only test for Dermatophagoides. B. tropicalis has been described in the tropical and subtropical 
regions, but is not routinely tested for in SA.
Objective. To ascertain the significance of B. tropicalis as an aeroallergen in northern coastal KwaZulu-Natal Province (KZN), a tropical 
environment, and in Johannesburg in the highveld, where the climate is milder and less humid.
Methods. Children aged 1 - 18 years with features of allergic rhinitis and/or asthma were recruited over a 6-month period from Alberlito 
Hospital in northern KZN and the Clinton Clinic in Johannesburg. SPTs included Dermatophagoides and B. tropicalis. Sensitisation was 
defined as a wheal 3 mm greater than the negative control.
Results. Eighty-five subjects were included, 50 in northern KZN and 35 in the Johannesburg arm; 52% of subjects in northern KZN and 
3% in Johannesburg were sensitised to B. tropicalis, with a significant difference between these centres (p<0.05). Of the 52% sensitised to 
B. tropicalis in northern KZN, half were sensitised only to B. tropicalis.
Conclusion. There is a high prevalence of B. tropicalis allergy in the tropical northern KZN region and a much lower prevalence in the 
Johannesburg region. Routine testing for B. tropicalis allergy should be employed in northern KZN.
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in the treatment of HDM allergy.[2] However, separate reagents for 
Dermatophagoides and Blomia are required. Current routine testing 
will not identify patients who suffer from B. tropicalis allergy, and 
the correct immunotherapy will therefore not be ordered for patients 
who need it. However, these patients can potentially be cured if a 
diagnosis of B. tropicalis allergy is made.
B. tropicalis should be individually tested for in areas of the world 
in which it is highly prevalent.[10] If the parts of SA in which B. 
tropicalis is of significance can be identified, testing in these regions 
can be advocated.
Objective
To determine the significance of B. tropicalis allergy among patients 
with allergic rhinitis and/or asthma in two different regions of SA, 
namely the northern coastal region of KwaZulu-Natal province 
(KZN) and the Johannesburg area. The northern KZN region is 
located at sea level and has a warm subtropical climate all year round. 
Johannesburg is situated in the highveld at 1 753 m above sea level, 
and the climate is milder and dry during most of the year.
Methods
A retrospective cross-sectional study design was employed. The 
study was undertaken at two private paediatric practices run by 
AVN, one situated at the Clinton Clinic in Johannesburg and the 
other at Alberlito Hospital in northern KZN. All the patients who 
presented with features of allergic rhinitis and/or asthma and had 
SPTs for aeroallergens between September 2013 and February 2014 
were included in the study. Only SPTs were utilised in this study to 
confirm sensitisation.
Two reagents were utilised for the SPTs at both centres to test 
specifically for HDM allergy. Both are manufactured by Stallergenes, 
France. The first was the conventional reagent used by most 
centres in SA that test for D. pteronyssinus and D. farinae allergy 
(D.  pteronyssinus and D. farinae mix). The second was a specific 
reagent that tested for B. tropicalis allergy specifically. A positive SPT 
result was defined as a wheal 3 mm greater than the negative control.
Statistical analysis
For both B. tropicalis and D. pteronyssinus/D. farinae, data were 
reported by province and the proportions of positive tests along 
with 95% confidence intervals (CIs). Comparisons between the 
two settings with respect to the proportions of positive B. tropicalis 
and D.  pteronyssinus/D. farinae tests, respectively, were done using 
Fisher’s exact test. The association between allergens and site was 
expressed in terms of odds ratios with 95% CIs. Testing was done at 
the 0.05 level of significance.
Ethical considerations
Full ethical approval was obtained from the Faculty of Health 
Sciences Research Ethics Committee of the University of Pretoria. 
Consent for use of clinical data was obtained from AVN, who was the 
primary physician at both study sites.
Results
A total of 87 charts from the two centres were screened; two were 
excluded because only ImmunoCAP testing for inhaled allergens was 
performed and not SPT analysis. All the patients were between 1 and 
18 years of age, with a male-to-female ratio of 2:1 (Table 1). The mean 
age of the study population was 7.4 years.
There was sensitisation to Dermatophagoides in 40.0% (95% 
CI 26.4 - 54.8) of children in the Alberlito arm as opposed to 
22.9% (95% CI 10.4 - 40.1) in the Clinton Clinic arm (Fig. 1). The 
difference between the two groups was not statistically significant 
(p=0.077). For B. tropicalis there was sensitisation in 52.0% (95% 
CI 37.4 - 66.3) of children in the Alberlito arm as opposed to 
2.9% (95% CI 0.1 - 14.9) in the Clinton Clinic arm (Fig. 2). The 
difference between the two groups was statistically significant 
(p<0.001).
On further analysis of the 33 patients in the Alberlito 
arm who tested positive for any HDM, 13/50 (26.0%) tested 
positive for only B. tropicalis, 7/50 (14.0%) positive for only 
Dermatophagoides spp., and 13/50 (26.0%) positive for both 
Table 1. Characteristics of all participants with asthma and 
allergic rhinitis included in the study 
Variable Johannesburg KZN
Patients, n 35 50
Age (years), mean (range) 7.4 (1 - 18) 7.4 (1 - 15)
Gender (M/F), n 27/8 30/20
Dermatophagoides (%)* 22.9 40.0
B. tropicalis (%)* 2.9 52.0
*% of patients with sensitisation to the specific HDM.
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Fig. 1. A comparison between positive SPTs for Dermatophagoides spp. at 
Alberlito Hospital (KZN) and Clinton Clinic (Johannesburg).
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Fig. 2. A comparison between positive SPTs for B. tropicalis at Alberlito 
Hospital (KZN) and Clinton Clinic (Johannesburg).
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Fig. 3. A summary of sensitisation to B. tropicalis and Dermatophagoides 
mites according to site.
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Blomia and Dermatophagoides (Fig. 3). In contrast, on analysis 
of the 8 patients in the Clinton Clinic group sensitised to any 
HDM, 7/35 (20.0%) tested positive only for Dermatophagoides 
and 1/35 (2.9%) tested positive for B. tropicalis. The only 
patient who tested positive for B. tropicalis was also positive for 
Dermatophagoides.
Discussion
This study demonstrates that allergy to Dermatophagoides spp. 
occurs both on the subtropical northern KZN coast of SA and in the 
temperate highveld region, with no statistical difference between the 
two regions. However, the proportion of B. tropicalis sensitisation 
was significantly higher in northern KZN, with 52% of individuals as 
opposed to only 2.9% for the highveld.
Previous studies have shown a higher prevalence of HDM allergy 
(Dermatophagoides spp.) along the coastline of SA compared 
with the highveld region.[5,6] However, the current study showed 
no statistical difference in the prevalence of Dermatophagoides 
between the KZN coast and the highveld. Reasons for the high 
prevalence of Dermatophagoides spp. in all regions include 
indoor heating in highveld houses, favouring proliferation of the 
mites. From this study it is evident that Dermatophagoides plays 
a significant role in allergic rhinitis and asthma among children 
both in the highveld and on the KZN coast. Guidelines should 
therefore require that routine testing for Dermatophagoides spp. is 
employed all over SA.
Around the world, B. tropicalis is abundant in the tropical 
and subtropical regions where there is high humidity and warm 
temperatures. One of the reasons Blomia is so prevalent along 
the KZN coastline may be the weather patterns in this region. 
The northern KZN area is located at sea level and has a humid 
climate much like that experienced in the tropical and subtropical 
belt. The warm Mozambique current that flows along the coast 
is responsible for warmer seas, warmer temperatures and higher 
humidity.[7] This warm and humid climate is much like that in 
the subtropical belt and could explain the high prevalence of B. 
tropicalis along this coastline. A 2010 study in Mexico City, which 
does not have a temperate climate, showed B. tropicalis allergy to 
be highly prevalent in patients with allergic rhinitis and asthma.[13] 
It therefore seems possible that there may be reasons in addition to 
humidity and temperature why Blomia may become significant in 
a particular area. Further studies are required to determine these 
reasons.
Routine testing for B. tropicalis is suggested in warm, tropical 
environments.[10] There are no formal studies from SA that describe 
the exact incidence of this mite in different regions of the country. 
According to expert opinion, 40% of allergic patients in the Western 
Cape are estimated to be allergic to B. tropicalis. Further studies to 
delineate the exact importance of B. tropicalis in this region are under 
way.[5,6] We have demonstrated that another region in SA, namely 
northern KZN, also has a high prevalence of HDM sensitisation 
(66.0% overall). B. tropicalis prevalence is high, with 26.0% of new 
subjects presenting with features of allergic rhinitis or asthma being 
sensitised to both Blomia and Dermatophagoides and 26.0% to Blomia 
alone. The routine testing currently employed in SA, either by in vivo 
or in vitro methods, would miss these cases.
B. tropicalis requires a specific reagent during SPT analysis. 
This is not usually included in most SPT panels for aeroallergens 
done in SA. The ImmunoCAP screening assay most commonly 
done for inhaled allergens in SA is the Phadiatop assay. While 
this is an excellent screening tool for the diagnosis of aeroallergen 
sensitisation in SA, and includes testing for grass, trees, cockroach, 
cat, dog and HDM, it tests only for allergy to Dermatophagoides spp. 
and not to Blomia. Since neither routine SPTs nor the Phadiatop 
assay screen for B. tropicalis allergy, current testing strategies are 
deficient in view of our finding of a high prevalence of Blomia 
sensitisation in northern KZN.
One of the strategies for treatment of allergic disease is avoidance 
of the known allergen. However, HDM allergen avoidance is not an 
option because HDMs are so abundant in the indoor environ ment. [2] 
As avoidance strategies are not possible, definitive treatment for 
HDM allergy, with the possibility of a cure, can be undertaken in 
the form of immunotherapy. Just as the diagnosis of HDM allergy 
differs between Dermatophagoides and Blomia, with specific regents 
required on SPT analysis, so too does immunotherapy for the two 
species differ, particular agents being required for each species. 
If routine testing is employed for Blomia in the northern KZN 
region, patients who are allergic to it can be offered the appropriate 
immunotherapy.
Study strengths and limitations
One of the strengths of this study is that it utilised SPT and not 
ImmunoCAP testing. SPT is a much more affordable option and can 
therefore be done on a wider scale. However, the specific reagent for 
Blomia should be included in highly prevalent areas.
The study is limited by the relatively small sample size and the 
relatively short period of time during which it was conducted. It 
also has geographical limitations in that it only involved two private 
paediatric practices in the each of the regions investigated.
Recommendations
It is recommended that more studies be undertaken to ascertain the 
significance of B. tropicalis as an aeroallergen in coastal and tropical 
parts of SA. This would offer a countrywide assessment of the 
prevalence of B. tropicalis and indicate those areas in which it should 
be routinely tested for.
Conclusion
There is a high prevalence of B. tropicalis allergy in tropical northern 
KZN and a much lower prevalence in the non-tropical Johannesburg 
region. Routine testing for B. tropicalis allergy should be employed in 
northern KZN.
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